RBM20 promotes doxorubicin-induced cardiotoxicity by Atp6v0a1 alternative splicing

Back

ESC Professional Premium Access

RBM20 promotes doxorubicin-induced cardiotoxicity by Atp6v0a1 alternative splicing

Session: Epigenetic targets in cardiovascular disease

Topic: Heart Failure

Speaker: Doctor Z. Qiu (Shanghai, CN)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Zeping Qiu

Rui Jin Hospital- Shanghai Jiaotong University School of Medicine, Shanghai (China)

0 follower

5 more presentations in this session

Targeting BRD4-HK2 reverses the meta-inflammatory shift in perivascular adipose tissue and rescues cardiometabolic vascular dysfunction.

Speaker: Assistant Professor A. Mengozzi (Pisa, IT)

Targeting the histone methyltransferase SETD7 rescues diabetes-induced impairment of angiogenic response by transcriptional repression of semaphorin 3G

Speaker: Doctor S. Mohammed (Zurich, CH)

Chromatin remodeling by the histone methyltransferase SETD2 drives cardiometabolic heart failure with preserved ejection fraction

Speaker: Doctor S. Costantino (Zurich, CH)

Epigenetic BET inhibitor apabetalone counters inflammatory and fibrotic processes in activated cardiac fibroblasts providing insight into reduced hospitalizations for heart failure in BETonMACE trial

Speaker: Doctor E. Kulikowski (Calgary, CA)

The BET inhibitor Apabetalone protects against heart failure with preserved ejection fraction by suppressing myocardial inflammation

Speaker: Doctor E. Gorica (Zurich, CH)

Access the full session

Epigenetic targets in cardiovascular disease

Speakers: Doctor Z. Qiu, Assistant Professor A. Mengozzi, Doctor S. Mohammed, Doctor S. Costantino, Doctor E. Kulikowski...

Access

Video

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources